News Focus
News Focus
Followers 48
Posts 23523
Boards Moderated 0
Alias Born 09/16/2012

Re: exwannabe post# 782210

Monday, 08/18/2025 11:33:03 AM

Monday, August 18, 2025 11:33:03 AM

Post# of 821332
There are likely many issues from the FDA’s opinion of all of it, to wondering why they never ran another trial, to ECA’s, to Patient level data, to selection criteria, to refreshed SOC figures, to extreme cost…

But meanwhile Cognate was sold and Advent is looking hot!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News